HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Peptide Reclassification 2026: What Researchers Want The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter